JUAN CHANFRAU: Open Payments
NPI 1053890491 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,045 in 50 payments from 11 companies in 2025. Trend: 2023 $861 · 2024 $1,215 · 2025 $1,045
Food & beverage: $1,045
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $249 |
| Madrigal Pharmaceuticals | 9 | $198 |
| Ardelyx, Inc. | 10 | $184 |
| QOL Medical, LLC | 8 | $167 |
| Exact Sciences Corporation | 3 | $62 |
| Lilly USA, LLC | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Braintree Laboratories, Inc. | 2 | $33 |
| Novo Nordisk Inc | 1 | $28 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
Products named: REZDIFFRA, IBSRELA, Sucraid, CREON, RINVOQ, Cologuard Collection Kit, VIBERZI, OMVOH.
Industry payments across FL — which companies pay providers there.
